CDX-301: a novel medical countermeasure for hematopoietic acute radiation syndrome in mice.
Model: Cobalt-60 gamma total body irradiation producing haematopoietic acute radiation syndrome; doses used included 7 Gy (myelosuppression), 9.25 Gy (LD70/30) and 8.0 to 10.5 Gy for dose reduction factor studies
A single subcutaneous dose of CDX-301 given from 24 h before to 24 h after total body irradiation significantly improved 30-day survival. Survival was not dose-dependent; 12 h and 24 h pre-irradiation dosing gave 100% survival, and 1600 ug/kg given 4 h after 9.25 Gy raised survival to 54% versus 22…
Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.